West Pharmaceutical Services (WST) Price to Sales (2009 - 2026)

West Pharmaceutical Services has disclosed Price to Sales across 18 years of filings, most recently posting 28.97 for Q2 2026.

• In Q2 2026, Price to Sales rose 41.17% year-over-year to 28.97; the TTM figure through Jun 2026 stood at 7.6 (up 42.95% YoY), while the FY2025 annual figure was 6.44, down 21.27% from the prior year.
• Price to Sales came in at 28.97 for Q2 2026 at West Pharmaceutical Services, up from 21.03 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 42.27 in Q1 2022 to a low of 20.52 in Q2 2025.
• Average Price to Sales over 5 years is 30.35, with a median of 29.07 recorded in 2022.
• Year-over-year, Price to Sales tumbled 48.32% in 2022 and surged 43.68% in 2023.
• Over 5 years, Price to Sales stood at 24.61 in 2022, then surged by 43.68% to 35.36 in 2023, then declined by 10.55% to 31.63 in 2024, then decreased by 22.19% to 24.61 in 2025, then gained by 17.74% to 28.97 in 2026.
• Per Business Quant data, the three most recent Price to Sales figures were 28.97 in Q2 2026, 21.03 in Q1 2026, and 24.61 in Q4 2025.